Farms.com Home   News

China to Keep Tariffs on U.S. Distillers Grains While Conducting Review

By Shivani Singh

China’s commerce ministry said on Tuesday it will maintain anti-dumping and anti-subsidy tariffs on imports of distillers grains (DDGS), a by-product of ethanol production used in animal feed, from the United States during a review.

The ministry will conduct expiry review investigations on the anti-dumping and anti-subsidy measures imposed on DDGS imports from the United States from Jan. 12 and it should end before Jan. 12, 2023, the ministry said in statements.

The ministry said it had on Oct. 25 received an application for expiry review of anti-dumping measures submitted by the China Alcoholic Drinks Association on behalf of China’s dried corn distiller’s grains industry.

China’s tariffs on U.S. DDGS were first implemented in 2016 at a rate of 33.8%, and its imports of the feed ingredient fell sharply.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.